9,10-dimethyl-1,2-benzanthracene has been researched along with Autoimmune Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YP; Muller, HK; Scarff, K; Toh, BH; Woods, GM | 1 |
| Depiante-Depaoli, M; Gilardoni, MB; Oviedo, M; Rabinovich, GA | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Autoimmune Diseases
| Article | Year |
|---|---|
Induction of peripheral tolerance in neonatally thymectomized mice by immunization through chemical carcinogen-altered skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Animals, Newborn; Antibody Formation; Autoimmune Diseases; Gastritis; Immune Tolerance; Immunization; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Picryl Chloride; Skin; Thymectomy | 1998 |
Prostate cancer induction in autoimmune rats and modulation of T cell apoptosis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Autoimmune Diseases; Autoimmunity; Flow Cytometry; Humans; Male; Precancerous Conditions; Prostate; Prostatic Neoplasms; Prostatitis; Rats; Rats, Wistar; Spleen; T-Lymphocytes | 1999 |